Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience

OBJECTIVE: To investigate in real-life the conversion from chronic migraine (CM) to episodic migraine (EM), specifically to EM with High-Frequency (HFEM: 8–14 monthly migraine days, MMDs), Medium-Frequency (MFEM, 4–7 MMDs), and Low-Frequency EM (LFEM, 0–3 MMDs), and its persistence during 1 year of...

Descripción completa

Detalles Bibliográficos
Autores principales: Altamura, Claudia, Brunelli, Nicoletta, Marcosano, Marilena, Aurilia, Cinzia, Egeo, Gabriella, Lovati, Carlo, Favoni, Valentina, Perrotta, Armando, Maestrini, Ilaria, Schiano Di Cola, Francesca, d’Onofrio, Florindo, Finocchi, Cinzia, Bertuzzo, Davide, Bono, Francesco, Ranieri, Angelo, Albanese, Maria, Messina, Roberta, Doretti, Alberto, Di Piero, Vittorio, Cevoli, Sabina, Barbanti, Piero, Vernieri, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243974/
https://www.ncbi.nlm.nih.gov/pubmed/35763113
http://dx.doi.org/10.1007/s00415-022-11226-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243974/
https://www.ncbi.nlm.nih.gov/pubmed/35763113
http://dx.doi.org/10.1007/s00415-022-11226-4

Ejemplares similares